Literature DB >> 21266913

Visfatin and cardio-cerebro-vascular disease.

Pei Wang1, Paul M Vanhoutte, Chao-Yu Miao.   

Abstract

Nicotinamide phosphoribosyltransferase is the rate-limiting enzyme that catalyzes the first step in the biosynthesis of nicotinamide adenine dinucleotide from nicotinamide. This protein was originally cloned as a putative pre-B cell colony-enhancing factor and also found to be a visceral fat-derived adipokine (visfatin). As a multifunctional protein, visfatin plays an important role in immunity, metabolism, aging, inflammation, and responses to stress. Visfatin also participates in several pathophysiological processes contributing to cardio-cerebro-vascular diseases, including hypertension, atherosclerosis, ischemic heart disease, and ischemic stroke. However, whether visfatin is a friend or a foe in these diseases remains uncertain. This brief review focuses on the current understanding of the complex role of visfatin in the cardio-cerebro-vascular system under normal and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21266913     DOI: 10.1097/FJC.0b013e31820eb8f6

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  A novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction.

Authors:  Katherine R Heberlein; Jenny Han; Adam C Straub; Angela K Best; Christoph Kaun; Johann Wojta; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

2.  Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression.

Authors:  Zhi-Yong Li; Si-Li Zheng; Pei Wang; Tian-Ying Xu; Yun-Feng Guan; Yi-Jie Zhang; Chao-Yu Miao
Journal:  CNS Neurosci Ther       Date:  2014-01-07       Impact factor: 5.243

Review 3.  Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Authors:  Maurizio Forte; Silvia Palmerio; Franca Bianchi; Massimo Volpe; Speranza Rubattu
Journal:  J Mol Med (Berl)       Date:  2019-03-12       Impact factor: 4.599

4.  Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.

Authors:  Qi-Sheng Ling; Sai-Long Zhang; Jia-Sheng Tian; Ming-He Cheng; Ai-Jun Liu; Feng-Hua Fu; Jian-Guo Liu; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2021-05-17       Impact factor: 7.169

5.  Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism.

Authors:  Bing Zhao; Meng Zhang; Xue Han; Xia-Yan Zhang; Qiong Xing; Xu Dong; Qiao-Juan Shi; Peng Huang; Yun-Bi Lu; Er-Qing Wei; Qiang Xia; Wei-Ping Zhang; Chun Tang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase.

Authors:  Tian-Ying Xu; Sai-Long Zhang; Guo-Qiang Dong; Xin-Zhu Liu; Xia Wang; Xiao-Qun Lv; Qi-Jun Qian; Ruo-Yu Zhang; Chun-Quan Sheng; Chao-Yu Miao
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

7.  Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases.

Authors:  Li-Ying Liu; Feng Wang; Xia-Yan Zhang; Peng Huang; Yun-Bi Lu; Er-Qing Wei; Wei-Ping Zhang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

Review 8.  Visfatin/Nampt: an adipokine with cardiovascular impact.

Authors:  Tania Romacho; Carlos F Sánchez-Ferrer; Concepción Peiró
Journal:  Mediators Inflamm       Date:  2013-06-16       Impact factor: 4.711

9.  Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT.

Authors:  Xia Wang; Tian-Ying Xu; Xin-Zhu Liu; Sai-Long Zhang; Pei Wang; Zhi-Yong Li; Yun-Feng Guan; Shu-Na Wang; Guo-Qiang Dong; Shu Zhuo; Ying-Ying Le; Chun-Quan Sheng; Chao-Yu Miao
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

Review 10.  Metrnl: a secreted protein with new emerging functions.

Authors:  Si-Li Zheng; Zhi-Yong Li; Jie Song; Jian-Min Liu; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.